TY - JOUR
T1 - Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia
AU - Onder, Ali Mirza
AU - Chandar, Jayanthi
AU - Billings, Anthony
AU - Diaz, Rosa
AU - Francoeur, Denise
AU - Abitbol, Carolyn
AU - Zilleruelo, Gaston
PY - 2009/4/8
Y1 - 2009/4/8
N2 - The aim of this retrospective study was to investigate if the application of chlorhexidine-based solutions (ChloraPrep®) to the exit site and the hub of long-term hemodialysis catheters could prevent catheter-related bacteremia (CRB) and prolong catheter survival when compared with povidone-iodine solutions. There were 20,784 catheter days observed. Povidone-iodine solutions (Betadine®) were used in the first half of the study and ChloraPrep® was used in the second half for all the patients. Both groups received chlorhexidine-impregnated dressings at the exit sites. The use of Chloraprep® significantly decreased the incidence of CRB (1.0 vs 2.2/1,000 catheter days, respectively, P = 0.0415), and hospitalization due to CRB (1.8 days vs 4.1 days/1,000 catheter days, respectively, P = 0.0416). The incidence of exit site infection was similar for the two groups. Both the period of overall catheter survival (207.6 days vs 161.1 days, P = 0.0535) and that of infection-free catheter survival (122.0 days vs 106.9 days, P = 0.1100) tended to be longer for the catheters cleansed with ChloraPrep®, with no statistical significance. In conclusion, chlorhexidine-based solutions are more effective for the prevention of CRB than povidone-iodine solutions. This positive impact cannot be explained by decreased number of exit site infections. This study supports the notion that the catheter hub is the entry site for CRB.
AB - The aim of this retrospective study was to investigate if the application of chlorhexidine-based solutions (ChloraPrep®) to the exit site and the hub of long-term hemodialysis catheters could prevent catheter-related bacteremia (CRB) and prolong catheter survival when compared with povidone-iodine solutions. There were 20,784 catheter days observed. Povidone-iodine solutions (Betadine®) were used in the first half of the study and ChloraPrep® was used in the second half for all the patients. Both groups received chlorhexidine-impregnated dressings at the exit sites. The use of Chloraprep® significantly decreased the incidence of CRB (1.0 vs 2.2/1,000 catheter days, respectively, P = 0.0415), and hospitalization due to CRB (1.8 days vs 4.1 days/1,000 catheter days, respectively, P = 0.0416). The incidence of exit site infection was similar for the two groups. Both the period of overall catheter survival (207.6 days vs 161.1 days, P = 0.0535) and that of infection-free catheter survival (122.0 days vs 106.9 days, P = 0.1100) tended to be longer for the catheters cleansed with ChloraPrep®, with no statistical significance. In conclusion, chlorhexidine-based solutions are more effective for the prevention of CRB than povidone-iodine solutions. This positive impact cannot be explained by decreased number of exit site infections. This study supports the notion that the catheter hub is the entry site for CRB.
KW - Catheter survival
KW - Catheter-related bacteremia
KW - Children
KW - Chlorhexidine
KW - Povidone-iodine
UR - http://www.scopus.com/inward/record.url?scp=68449084541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68449084541&partnerID=8YFLogxK
U2 - 10.1007/s00467-009-1154-5
DO - 10.1007/s00467-009-1154-5
M3 - Article
C2 - 19296135
AN - SCOPUS:68449084541
VL - 24
SP - 1741
EP - 1747
JO - Pediatric Nephrology
JF - Pediatric Nephrology
SN - 0931-041X
IS - 9
ER -